Hannoxin Biotechnology was established in 2017 and is located at No. 688 Yinzang Road, Linhu Town, Wuzhong District, Suzhou City. It has multiple 100,000-level purification workshops with full physical, chemical and biological performance testing capabilities, all designed in compliance with GMP standards. requirements.
The company takes "technological innovation, winning by quality, customer satisfaction, and continuous improvement" as its quality policy, adheres to the business philosophy of "harmonious development of society, enterprises, and employees" and strives to become a well-known high-tech enterprise in the domestic medical device industry.
Today, Shaxi Town held the opening ceremony of the Hannuoxin Biomedical Beauty Headquarters Base. The project is a key project of Suzhou City in 2024, with a total investment of about 500 million yuan. Wang Xiangyuan, Secretary of the Municipal Party Committee, Tao Ran, an academician of the United Nations International Academy of Ecological Life Safety Sciences, and Yang Chenglin, Chairman of Jiangsu Hannuoxin Biotechnology Co., Ltd. attended the ceremony.
Single-use sterile injection needles have become commonplace in modern healthcare practice. These injection needles are designed to ensure that every injection is safe and free from the risk of infection.